Auvi-Q

Product NDC: 85766-276
11-digit product format: 857660276
Labeler code: 85766
Product ID: 85766-276_5bbbd802-1766-6081-e063-6294a90af4a5
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: epinephrine
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR
Labeler: Sportpharm LLC
Application: NDA201739
Marketing category: NDA
Marketing start: 2012-11-15
Substance: EPINEPHRINE
Active strength: .15 mg/.15mL
Pharmacologic classes: Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N201739-001	AUVI-Q	EPINEPHRINE	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10
N201739-002	AUVI-Q	EPINEPHRINE	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10
N201739-003	AUVI-Q	EPINEPHRINE	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N201739-001	BX
N201739-002	BX

Orange Book patents#

Current patent rows page 1 of 1 · 24 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N201739-001	11590286	2026-12-12		Drug product	2023-03-29
N201739-001	8206360	2027-02-27		Drug product	2013-03-21
N201739-001	7947017	2028-03-12		Drug product	2013-02-22
N201739-001	8231573	2028-11-25		Drug product	2012-08-21
N201739-001	8226610	2029-04-10		Drug product	2012-08-21
N201739-001	8021344	2029-11-02		Drug product	2013-07-26
N201739-002	11590286	2026-12-12		Drug product	2023-03-29
N201739-002	8206360	2027-02-27		Drug product
N201739-002	7947017	2028-03-12		Drug product
N201739-002	8231573	2028-11-25		Drug product
N201739-002	8226610	2029-04-10		Drug product
N201739-002	8021344	2029-11-02		Drug product	2013-07-26
N201739-002	10688244	2037-12-21	U-2980	Drug product	2020-11-04
N201739-002	10842938	2037-12-21	U-2980	Drug product	2020-12-10
N201739-002	11771830	2037-12-21	U-2980	Drug product	2023-12-20
N201739-003	11590286	2026-12-12		Drug product	2023-03-29
N201739-003	8206360	2027-02-27		Drug product	2017-12-15
N201739-003	7947017	2028-03-12		Drug product	2017-12-15
N201739-003	8231573	2028-11-25		Drug product	2017-12-15
N201739-003	8226610	2029-04-10		Drug product	2017-12-15
N201739-003	8021344	2029-11-02		Drug product	2017-12-15
N201739-003	10688244	2037-12-21	U-2980	Drug product	2020-11-04
N201739-003	10842938	2037-12-21	U-2980	Drug product	2020-12-10
N201739-003	11771830	2037-12-21	U-2980	Drug product	2023-12-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201739-002	AUVI-Q	EQ 0.15MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD, RS	2012-08-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201739-003	AUVI-Q	EQ 0.1MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2017-11-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N201739-001	AUVI-Q	EQ 0.3MG/DELIVERY	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	BX	RLD	2012-08-10	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N201739-001	BX	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	BX	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N201739-001	BX	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	BX	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N201739-001	BX	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201739-002	BX	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201739-001	BX	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201739-002	BX	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N201739-001	BX	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201739-002	BX	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201739-001	BX	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201739-002	BX	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201739-001	BX	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201739-002	BX	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201739-001	BX	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201739-002	BX	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201739-001	BX	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201739-002	BX	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201739-001	BX	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201739-002	BX	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201739-001	BX	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201739-002	BX	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N201739-001	BX	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N201739-002	BX	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201739-001	BX	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201739-002	BX	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N201739-001	BX	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N201739-002	BX	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N201739-001	BX	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N201739-002	BX	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N201739-001	BX	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N201739-002	BX	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N201739-001	BX	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N201739-002	BX	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N201739-001	BX	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N201739-002	BX	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N201739-001	BX	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N201739-002	BX	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N201739-001	BX	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N201739-002	BX	1	`74a2ff9319b5…`

Observed Orange Book patent history#

Patent history page 1 of 70 · 2,773 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N201739-001	11590286	2026-12-12		Drug product	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-001	8206360	2027-02-27		Drug product	2013-03-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-001	7947017	2028-03-12		Drug product	2013-02-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-001	8231573	2028-11-25		Drug product	2012-08-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-001	8226610	2029-04-10		Drug product	2012-08-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-001	8021344	2029-11-02		Drug product	2013-07-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	11590286	2026-12-12		Drug product	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	8206360	2027-02-27		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	7947017	2028-03-12		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	8231573	2028-11-25		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	8226610	2029-04-10		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	8021344	2029-11-02		Drug product	2013-07-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	10688244	2037-12-21	U-2980	Drug product	2020-11-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	10842938	2037-12-21	U-2980	Drug product	2020-12-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-002	11771830	2037-12-21	U-2980	Drug product	2023-12-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	11590286	2026-12-12		Drug product	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	8206360	2027-02-27		Drug product	2017-12-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	7947017	2028-03-12		Drug product	2017-12-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	8231573	2028-11-25		Drug product	2017-12-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	8226610	2029-04-10		Drug product	2017-12-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	8021344	2029-11-02		Drug product	2017-12-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	10688244	2037-12-21	U-2980	Drug product	2020-11-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	10842938	2037-12-21	U-2980	Drug product	2020-12-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201739-003	11771830	2037-12-21	U-2980	Drug product	2023-12-20	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N201739-001	11590286	2026-12-12		Drug product	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-001	8206360	2027-02-27		Drug product	2013-03-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-001	7947017	2028-03-12		Drug product	2013-02-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-001	8231573	2028-11-25		Drug product	2012-08-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-001	8226610	2029-04-10		Drug product	2012-08-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-001	8021344	2029-11-02		Drug product	2013-07-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	11590286	2026-12-12		Drug product	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	8206360	2027-02-27		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	7947017	2028-03-12		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	8231573	2028-11-25		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	8226610	2029-04-10		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	8021344	2029-11-02		Drug product	2013-07-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	10688244	2037-12-21	U-2980	Drug product	2020-11-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	10842938	2037-12-21	U-2980	Drug product	2020-12-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-002	11771830	2037-12-21	U-2980	Drug product	2023-12-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201739-003	11590286	2026-12-12		Drug product	2023-03-29	`caaa826d4ba7…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Auvi-Q
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
EPINEPHRINE	.15 mg/.15mL

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Auvi-Q	EPINEPHRINE	kaleo, Inc	6180fb40-7fca-4602-b3da-ce62b8cd2470	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
AUVI-Q	AUVI-Q	HF Acquisition Co LLC, DBA HealthFirst	23e772f8-26d0-b516-e063-6394a90ada58	2025-05-07	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
Auvi-Q	EPINEPHRINE	Medical Purchasing Solutions, LLC	296a9023-b5c6-6102-e063-6294a90af87e	2024-12-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
Auvi-Q	EPINEPHRINE	Medical Purchasing Solutions, LLC	29299266-69c5-b1a7-e063-6394a90a25f8	2024-12-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
AUVI-Q	AUVI-Q	HF Acquisition Co LLC, DBA HealthFirst	23fd4c93-0a42-922e-e063-6394a90a1887	2024-10-08	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
AUVI-Q	AUVI-Q	HF Acquisition Co LLC, DBA HealthFirst	23fdb616-0c60-44fe-e063-6394a90ad8f1	2024-10-08	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
EPINEPHRINE	EPINEPHRINE	HF Acquisition Co LLC, DBA HealthFirst	98aaa648-fc25-754d-e053-2995a90a7051	2024-03-08	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
EPINEPHRINE	EPINEPHRINE	HF Acquisition Co LLC, DBA HealthFirst	7664bb0d-dc1a-ca8b-e053-2991aa0ad627	2024-02-19	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
Auvi-Q	EPINEPHRINE	Medical Purchasing Solutions, LLC	8f110633-bf37-458d-e053-2a95a90a8fa9	2023-04-26	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739
Auvi-Q	EPINEPHRINE	Medical Purchasing Solutions, LLC	8f00231e-be88-49fe-e053-2a95a90ab6dd	2023-04-26	Warnings, Adverse reactions	Exact identifier application applno (NDA): 201739 application number: NDA201739

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
YKH834O4BH	EPINEPHRINE	51-43-4	EPINEPHRINE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
85766-276-02	85766027602	2 DOSE PACK in 1 CARTON (85766-276-02) / .15 mL in 1 DOSE PACK	2 dose pack	2026-09-18	No	No	Current